MERCK KGAA NAM.SP.ADR Total Assets

Latest as of December 2025: €51.53 Billion EUR ≈ $60.24 Billion USD

MERCK KGAA NAM.SP.ADR total assets. Based on the latest financial reports, MERCK KGAA NAM.SP.ADR (MRKC) holds total assets worth €51.53 Billion EUR (≈ $60.24 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see MRKC market cap for the company's overall valuation and market capitalisation.

Total Assets of MERCK KGAA NAM.SP.ADR (2020–2025)

Total assets of MERCK KGAA NAM.SP.ADR from 2020 to 2025. This chart illustrates how MERCK KGAA NAM.SP.ADR's total assets have evolved over time, based on quarterly financial data. See MRKC stock price and chart for real-time trading data and today's change.

MERCK KGAA NAM.SP.ADR - Asset Composition Analysis

MERCK KGAA NAM.SP.ADR Total Assets Breakdown (December 2025)

MERCK KGAA NAM.SP.ADR total assets breakdown as of December 2025. MERCK KGAA NAM.SP.ADR's total assets of €51.53 Billion consist of 25.7% current assets and 74.3% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 4.5%
Accounts Receivable €3.95 Billion 7.7%
Inventory €4.56 Billion 8.9%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €7.66 Billion 14.9%
Goodwill €17.93 Billion 34.8%

Asset Composition Trend (2020–2025)

This chart illustrates how MERCK KGAA NAM.SP.ADR's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore MERCK KGAA NAM.SP.ADR (MRKC) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: MERCK KGAA NAM.SP.ADR's current assets represent 25.7% of total assets in 2025, an increase from 22.2% in 2020.
  • Cash Position: Cash and equivalents constituted 4.5% of total assets in 2025, up from 2.7% in 2020.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, a decrease from 56.0% in 2020.
  • Asset Diversification: The largest asset category is goodwill at 34.8% of total assets.

MERCK KGAA NAM.SP.ADR Competitors by Total Assets

Key competitors of MERCK KGAA NAM.SP.ADR based on total assets are shown below.

Company Country Total Assets
GALDERMA GROUP AG
NYSE:GALDY
USA $13.39 Billion
Takeda Pharmaceutical Company Limited
F:TKDA
Germany €15.41 Trillion
Galderma Group N
SW:GALD
Switzerland CHF12.88 Billion
Enzymatica publ AB
ST:ENZY
Sweden Skr149.24 Million
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
China CN¥13.98 Billion
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
China CN¥17.01 Billion
Kangmei Pharmaceutical Co Ltd
SHG:600518
China CN¥13.68 Billion
Walvax BioTech
SHE:300142
China CN¥10.50 Billion

MERCK KGAA NAM.SP.ADR - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.46 1.19 1.36
Quick Ratio 0.96 0.79 0.84
Cash Ratio 0.00 0.00 0.00
Working Capital €4.19 Billion €2.15 Billion €3.40 Billion

MERCK KGAA NAM.SP.ADR - Advanced Valuation Insights

This section examines the relationship between MERCK KGAA NAM.SP.ADR's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.72
Latest Market Cap to Assets Ratio 0.33
Asset Growth Rate (YoY) -0.1%
Total Assets €51.53 Billion
Market Capitalization $17.07 Billion USD

Valuation Analysis

Below Book Valuation: The market values MERCK KGAA NAM.SP.ADR's assets below their book value (0.33x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: MERCK KGAA NAM.SP.ADR's assets decreased by 0.1% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for MERCK KGAA NAM.SP.ADR (2020–2025)

The table below shows the annual total assets of MERCK KGAA NAM.SP.ADR from 2020 to 2025.

Year Total Assets Change
2025-12-31 €51.53 Billion
≈ $60.24 Billion
-0.08%
2024-12-31 €51.57 Billion
≈ $60.29 Billion
+6.33%
2023-12-31 €48.49 Billion
≈ $56.70 Billion
-0.08%
2022-12-31 €48.53 Billion
≈ $56.74 Billion
+6.99%
2021-12-31 €45.36 Billion
≈ $53.03 Billion
+8.53%
2020-12-31 €41.80 Billion
≈ $48.86 Billion
--

About MERCK KGAA NAM.SP.ADR

F:MRKC Germany Drug Manufacturers - Specialty & Generic
Market Cap
$17.07 Billion
€14.60 Billion EUR
Market Cap Rank
#1431 Global
#323 in Germany
Share Price
€22.60
Change (1 day)
-2.59%
52-Week Range
€20.20 - €26.20
All Time High
€44.30
About

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more